- Home
- XMTR vs MRVI Comparison
XMTR vs MRVI Comparison
Compare XMTR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- MRVI
- Stock Information
- Founded
- XMTR 2013
- MRVI 2020
- Country
- XMTR United States
- MRVI United States
- Employees
- XMTR N/A
- MRVI N/A
- Industry
- XMTR Industrial Machinery/Components
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- MRVI Health Care
- Exchange
- XMTR Nasdaq
- MRVI Nasdaq
- Market Cap
- XMTR 1.0B
- MRVI 809.2M
- IPO Year
- XMTR 2021
- MRVI 2020
- Fundamental
- Price
- XMTR $40.29
- MRVI $5.60
- Analyst Decision
- XMTR Buy
- MRVI Buy
- Analyst Count
- XMTR 8
- MRVI 11
- Target Price
- XMTR $32.00
- MRVI $10.03
- AVG Volume (30 Days)
- XMTR 484.1K
- MRVI 1.6M
- Earning Date
- XMTR 11-05-2024
- MRVI 11-07-2024
- Dividend Yield
- XMTR N/A
- MRVI N/A
- EPS Growth
- XMTR N/A
- MRVI N/A
- EPS
- XMTR N/A
- MRVI N/A
- Revenue
- XMTR $525,128,000.00
- MRVI $276,920,000.00
- Revenue This Year
- XMTR $19.60
- MRVI N/A
- Revenue Next Year
- XMTR $19.06
- MRVI $3.41
- P/E Ratio
- XMTR N/A
- MRVI N/A
- Revenue Growth
- XMTR 21.19
- MRVI N/A
- 52 Week Low
- XMTR $11.08
- MRVI $4.28
- 52 Week High
- XMTR $38.74
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- XMTR 85.42
- MRVI 49.01
- Support Level
- XMTR $33.15
- MRVI $5.45
- Resistance Level
- XMTR $35.34
- MRVI $6.01
- Average True Range (ATR)
- XMTR 1.85
- MRVI 0.34
- MACD
- XMTR 0.40
- MRVI 0.12
- Stochastic Oscillator
- XMTR 92.16
- MRVI 63.43
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.